Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-08-08 |
2024-06 |
-0.09 |
N/A |
N/A |
N/A |
2024-05-14 |
2024-03 |
-0.06 |
-0.1 |
-0.04 |
-66.67% |
2024-04-01 |
2023-12 |
0 |
-0.09 |
N/A |
N/A |
2023-11-14 |
2023-09 |
0 |
-0.07 |
N/A |
N/A |
2023-08-10 |
2023-06 |
0 |
-0.09 |
N/A |
N/A |
2023-05-15 |
2023-03 |
0 |
-0.08 |
N/A |
N/A |
Date |
Name |
Relation |
Quantity |
Description |
2022-07-04 |
Elsley (David) |
Director of Issuer |
1.15M |
Acquisition or disposition by gift |
2022-03-30 |
Torreamione (Guilermo) |
Senior Officer of Issuer |
89.16K |
Acquisition or disposition in the public market |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
MMCAP International, Inc. SPC |
2.95M |
2.63M |
4.56% |
2023-06-29 |
AXS Investments, LLC |
1.30M |
1.16M |
2.00% |
2023-06-29 |
AdvisorShares Investments, LLC |
1.22M |
1.09M |
1.88% |
2023-06-29 |
Tejara Capital Ltd |
497.06K |
442.38K |
0.77% |
2023-06-29 |
Bank of Montreal/Can/ |
112.18K |
99.84K |
0.17% |
2023-06-29 |
We Are One Seven, LLC |
100.00K |
89.00K |
0.15% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-05-30 |
Investment Managers Ser Tr II-AXS Cannabis ETF |
1.52M |
1.02M |
2.35% |
2023-09-29 |
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF |
1.21M |
1.08M |
1.86% |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
52.44K |
35.35K |
0.08% |